These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21373651)

  • 1. A report from the 46th Annual Meeting of the European Association for the Study of Diabetes (September 20-24, 2010 - Stockholm, Sweden).
    Rabasseda X
    Drugs Today (Barc); 2011 Jan; 47(1):77-95. PubMed ID: 21373651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A report from the 47th European Association for the Study of Diabetes annual meeting (September 12-16, 2011 - Lisbon, Portugal).
    Rabasseda X
    Drugs Today (Barc); 2011 Dec; 47(12):923-34. PubMed ID: 22348917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into antidiabetic therapies: a report from the 43rd annual meeting of the European Association for the Study of Diabetes.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E28. PubMed ID: 18297140
    [No Abstract]   [Full Text] [Related]  

  • 4. From insulin to incretins: a report from the 67th scientific sessions of the American Diabetes Association.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Aug; 11():E21. PubMed ID: 18297152
    [No Abstract]   [Full Text] [Related]  

  • 5. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 67 th annual meeting of the American Diabetes Association.
    Colca JR
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1735-9. PubMed ID: 17922635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of incretin-based therapies in the management of type 2 diabetes.
    Bandyopadhyay P
    Drug News Perspect; 2009 Nov; 22(9):559-67. PubMed ID: 20072733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
    Choby B
    FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Fitchett DH; Udell JA; Inzucchi SE
    Eur J Heart Fail; 2017 Jan; 19(1):43-53. PubMed ID: 27653447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
    Inzucchi SE
    Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral combination therapy in primary care.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 May; 65(5):574-5. PubMed ID: 26028398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapies in diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006 Oct; 19(8):499-507. PubMed ID: 17160152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Diabetes Association - 67th scientific sessions.
    Filson S
    IDrugs; 2007 Sep; 10(9):600-2. PubMed ID: 17786837
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innovations in the treatment of type 2 diabetes mellitus: use of incretins].
    Dedov II; Shestakova MV; Sukhareva OIu
    Ter Arkh; 2010; 82(10):5-10. PubMed ID: 21341455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale.
    Yassin SA; Aroda VR
    Drug Des Devel Ther; 2017; 11():923-937. PubMed ID: 28356718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster and diabetes.
    Kalra S; Chawla A
    J Pak Med Assoc; 2016 Aug; 66(8):1042-3. PubMed ID: 27524548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of diabetes and diabetes medications on bone health.
    Gilbert MP; Pratley RE
    Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.